Novel Pra-peptide hydrogel shows promise for treating ocular inflammation
The Pra-ffd hydrogel demonstrated improved bioavailability and reduced ocular inflammation in preclinical models.
Therapeutic Area
Therapeutic area intelligence for Ocular Inflammation with 1 indexed intelligence signal across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.